• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多培沙明未能维持慢性心力衰竭患者的血流动力学改善。

Failure of dopexamine to maintain haemodynamic improvement in patients with chronic heart failure.

作者信息

Murphy J J, Hampton J R

机构信息

Department of Medicine, University Hospital, Nottingham.

出版信息

Br Heart J. 1988 Jul;60(1):45-9. doi: 10.1136/hrt.60.1.45.

DOI:10.1136/hrt.60.1.45
PMID:2900644
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1216513/
Abstract

Ten patients with chronic heart failure were given a continuous infusion of dopexamine after an initial stage of dose titration. On the dose selected the cardiac index initially rose by 56%, as a result of an increase in both heart rate and stroke volume index. Systemic vascular resistance fell by 34% and the mean arterial pressure did not change. Within 18 hours of the start of the continuous infusion, however, all the variables except heart rate had returned to preinfusion values. Nine of the 10 patients were withdrawn from the 48 hour study, six because of haemodynamic deterioration and two because of side effects. If the premature loss of therapeutic effect reflects an intrinsic property of this agent, dopexamine may be of limited clinical value.

摘要

10例慢性心力衰竭患者在初始剂量滴定阶段后持续输注多培沙明。在选定的剂量下,心脏指数最初上升了56%,这是心率和每搏量指数增加的结果。全身血管阻力下降了34%,平均动脉压未发生变化。然而,在持续输注开始后的18小时内,除心率外的所有变量均恢复到输注前的值。10例患者中有9例退出了48小时的研究,6例因血流动力学恶化,2例因副作用。如果治疗效果过早丧失反映了该药物的内在特性,那么多培沙明的临床价值可能有限。

相似文献

1
Failure of dopexamine to maintain haemodynamic improvement in patients with chronic heart failure.多培沙明未能维持慢性心力衰竭患者的血流动力学改善。
Br Heart J. 1988 Jul;60(1):45-9. doi: 10.1136/hrt.60.1.45.
2
Efficacy and safety of a short-term (6-h) intravenous infusion of dopexamine in patients with severe congestive heart failure: a randomized, double-blind, parallel, placebo-controlled multicenter study.多巴酚丁胺短期(6小时)静脉输注治疗重度充血性心力衰竭患者的疗效与安全性:一项随机、双盲、平行、安慰剂对照的多中心研究。
J Am Coll Cardiol. 1991 Aug;18(2):383-90. doi: 10.1016/0735-1097(91)90590-6.
3
Haemodynamic response to dopexamine hydrochloride in postinfarction heart failure: lack of tolerance after continuous infusion.盐酸多培沙明对心肌梗死后心力衰竭的血流动力学反应:持续输注后无耐受性。
Br Heart J. 1988 Dec;60(6):489-96. doi: 10.1136/hrt.60.6.489.
4
Prolonged infusion of varied doses of dopexamine hydrochloride for low cardiac output after cardiac surgery.心脏手术后低心排血量时不同剂量盐酸多培沙明的持续输注
J Cardiothorac Vasc Anesth. 1992 Oct;6(5):568-72. doi: 10.1016/1053-0770(92)90099-s.
5
Short-term haemodynamic effects of dopexamine in patients with chronic congestive heart failure.
Eur Heart J. 1986 Aug;7(8):697-703. doi: 10.1093/oxfordjournals.eurheartj.a062125.
6
Hemodynamic effects of dopexamine hydrochloride administered by an intracoronary infusion technique.通过冠状动脉内输注技术给予盐酸多培沙明的血流动力学效应。
J Cardiothorac Anesth. 1989 Oct;3(5 Suppl 1):15. doi: 10.1016/0888-6296(89)90758-8.
7
Administration of dopexamine, a new adrenergic agent, in cardiorespiratory failure.新型肾上腺素能药物多培沙明在心衰中的应用。
Chest. 1989 Dec;96(6):1233-6. doi: 10.1378/chest.96.6.1233.
8
[Dopexamine: a new dopaminergic agonist].多培沙明:一种新型多巴胺能激动剂
Ann Fr Anesth Reanim. 1993;12(3):308-20. doi: 10.1016/s0750-7658(05)80658-6.
9
Cardiovascular pharmacology of dopexamine in low output congestive heart failure.多培沙明在低输出量充血性心力衰竭中的心血管药理学
Am J Cardiol. 1988 Jul 1;62(1):94-9. doi: 10.1016/0002-9149(88)91371-9.
10
The use of dopexamine after cardiac surgery: acute and long-term effects in patients with impaired cardiac function.心脏手术后使用多培沙明:对心功能受损患者的急性和长期影响。
Thorac Cardiovasc Surg. 1992 Dec;40(6):378-81. doi: 10.1055/s-2007-1020184.

引用本文的文献

1
Effects of chronic intravenous infusions of dopexamine and isoprenaline to rats on D1-, beta 1- and beta 2-receptor-mediated responses.对大鼠进行多巴胺丁胺和异丙肾上腺素慢性静脉输注对D1、β1和β2受体介导反应的影响。
Br J Pharmacol. 1994 Jun;112(2):595-603. doi: 10.1111/j.1476-5381.1994.tb13116.x.
2
Dopexamine in congestive heart failure: how do the pharmacological activities translate into the clinical situation?多培沙明用于充血性心力衰竭:其药理活性如何转化为临床实际疗效?
Basic Res Cardiol. 1989;84 Suppl 1:177-86. doi: 10.1007/BF02650357.
3
The effects of dopexamine, a new dopamine analogue, on platelet function in stress.新型多巴胺类似物多培沙明在应激状态下对血小板功能的影响。
Br J Clin Pharmacol. 1990 Jul;30(1):87-95. doi: 10.1111/j.1365-2125.1990.tb03747.x.
4
Dopexamine hydrochloride. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in acute cardiac insufficiency.盐酸多培沙明。其药效学和药代动力学特性以及在急性心脏功能不全中的治疗潜力综述。
Drugs. 1990 Feb;39(2):308-30. doi: 10.2165/00003495-199039020-00009.

本文引用的文献

1
Tolerance to dobutamine after a 72 hour continuous infusion.
Am J Med. 1980 Aug;69(2):262-6. doi: 10.1016/0002-9343(80)90387-3.
2
Combined vasodilator and inotropic therapy of heart failure: experimental and clinical concepts.心力衰竭的血管扩张剂与正性肌力药物联合治疗:实验与临床概念
Am Heart J. 1981 Sep;102(3 Pt 2):500-8. doi: 10.1016/0002-8703(81)90738-9.
3
Decreased lymphocyte beta-adrenergic-receptor density in patients with heart failure and tolerance to the beta-adrenergic agonist pirbuterol.心力衰竭患者淋巴细胞β-肾上腺素能受体密度降低及对β-肾上腺素能激动剂吡布特罗的耐受性
N Engl J Med. 1981 Jul 23;305(4):185-90. doi: 10.1056/NEJM198107233050402.
4
Beta-adrenoceptors of the human myocardium: determination of beta 1 and beta 2 subtypes by radioligand binding.人心肌中的β-肾上腺素能受体:通过放射性配体结合法测定β1和β2亚型
Br J Pharmacol. 1983 Dec;80(4):711-7. doi: 10.1111/j.1476-5381.1983.tb10062.x.
5
Dopamine--clinical uses of an endogenous catecholamine.多巴胺——一种内源性儿茶酚胺的临床应用。
N Engl J Med. 1974 Oct 3;291(14):707-10. doi: 10.1056/NEJM197410032911405.
6
Acute haemodynamic and metabolic effects of dopexamine, a new dopaminergic receptor agonist, in patients with chronic heart failure.新型多巴胺能受体激动剂多培沙明对慢性心力衰竭患者的急性血流动力学和代谢影响
Br Heart J. 1985 Sep;54(3):313-20. doi: 10.1136/hrt.54.3.313.
7
The effects of dopexamine on the cardiovascular system of the dog.多培沙明对犬心血管系统的影响。
Br J Pharmacol. 1985 Jul;85(3):609-19. doi: 10.1111/j.1476-5381.1985.tb10555.x.
8
Enalapril reduces the catecholamine response to exercise in patients with heart failure.
Eur J Clin Pharmacol. 1986;30(4):485-7. doi: 10.1007/BF00607965.
9
Loss of high affinity cardiac beta adrenergic receptors in dogs with heart failure.心力衰竭犬心脏高亲和力β肾上腺素能受体的丧失
J Clin Invest. 1985 Dec;76(6):2259-64. doi: 10.1172/JCI112235.
10
Cardiac pumping capability and prognosis in heart failure.心力衰竭时的心脏泵血能力与预后
Lancet. 1986 Dec 13;2(8520):1360-3. doi: 10.1016/s0140-6736(86)92006-4.